Active Ingredient: GEFITINIB
Proprietary Name: IRESSA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N206995
Product Number: 001
Approval Date: Jul 13, 2015
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Prescription
Patent and Exclusivity Information
